65 Participants Needed

Lifestyle Changes for Breast Cancer

(IMPACT-Women Trial)

Recruiting at 1 trial location
RS
Overseen ByRachel Sherrington, Bkin
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of Alberta
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to explore whether lifestyle changes can assist breast cancer patients during chemotherapy. It will test if time-restricted eating (eating within a specific time window), improved nutrition, and reduced sitting can decrease fat build-up and enhance heart health. Participants will join one of two groups: one follows a structured diet and activity plan, while the other receives general nutrition advice and standard care. Women diagnosed with early to mid-stage breast cancer and starting chemotherapy might be suitable candidates if they are willing to adjust their eating and activity habits. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance cancer care through lifestyle changes.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you have diabetes and require insulin, you may not be eligible to participate.

What prior data suggests that these lifestyle changes are safe for breast cancer patients?

Research has shown that time-restricted eating (TRE), combined with healthy eating and reduced sedentary behavior, is generally well-tolerated by people with cancer. Studies have found that integrating TRE with these lifestyle changes is both feasible and safe. Specifically, one study discovered that an eight-week period of TRE was manageable for participants and helped lower the risk of heart disease in older breast cancer survivors. These findings suggest that such lifestyle changes can be safely incorporated into the lives of breast cancer patients, potentially leading to better health outcomes.12345

Why are researchers excited about this trial?

Researchers are excited about these lifestyle changes for breast cancer because they offer a fresh approach by focusing on time-restricted eating, nutrition education, and reducing sedentary behavior. Unlike traditional treatments that mainly rely on drugs and chemotherapy, these strategies aim to improve overall health and well-being, potentially enhancing the effectiveness of standard treatments. By incorporating a holistic approach with tools like a Fitbit monitor for tracking progress, these interventions could empower patients to actively participate in their health journey, possibly leading to better outcomes and quality of life during treatment.

What evidence suggests that these lifestyle changes could be effective for breast cancer patients?

Research shows that time-restricted eating (TRE) can benefit people with cancer, including those undergoing chemotherapy for breast cancer. In this trial, participants in the "Time-Restricted Eating and Sedentary Time Reduction" arm will follow TRE, receive nutritional education, and work on reducing sedentary time. Studies have found that TRE, combined with healthy eating and increased activity, may improve treatment outcomes and quality of life. Early findings suggest that TRE is not only feasible and acceptable for cancer patients but may also offer cancer-related benefits. This method could aid in weight management and overall health, potentially lowering the risk of heart problems for breast cancer survivors. These lifestyle changes aim to control unwanted fat in specific areas, which is linked to heart health and fitness.12356

Who Is on the Research Team?

RT

Richard Thompson, PhD

Principal Investigator

University of Alberta

Are You a Good Fit for This Trial?

This trial is for women over 18 with stage I, II, or III breast cancer who are about to start chemotherapy. They must be able to perform daily activities (ECOG <3), have their oncologist's approval, speak English, and commit to the study intervention.

Inclusion Criteria

I was born female.
I am over 18 years old.
Willing and able to adhere to study intervention
See 3 more

Exclusion Criteria

I have diabetes and need insulin or my A1c is over 10%.
Individuals who do not have access to a smart phone with Bluetooth capability or at least a shared cell phone with someone in the same household
Research MRI contraindications (e.g., pacemaker, magnetic implants, pregnancy)
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Chemotherapy Treatment

Participants receive standard chemotherapy treatment along with a behavioral intervention involving time-restricted eating, diet quality improvements, and reduced sedentary time

24 weeks
Regular visits for chemotherapy and intervention monitoring

Follow-up

Participants are monitored for changes in ectopic fat, cardiometabolic profile, and chemotherapy outcomes

2 years
Periodic assessments at baseline, 24 weeks, and 2 years

Long-term Follow-up

Tracking long-term health effects of participation through participants' electronic medical records

Up to 10 years after study completion

What Are the Treatments Tested in This Trial?

Interventions

  • Time restricted eating, nutrition education, and sedentary time reduction strategies
Trial Overview The study tests if a behavioral intervention with time-restricted eating, better diet quality, and less sitting time can reduce fat accumulation and improve heart health compared to standard care in breast cancer patients during chemotherapy.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Time-Restricted Eating and Sedentary Time ReductionExperimental Treatment1 Intervention
Group II: Nutrition and Exercise GuidelinesActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials
957
Recruited
437,000+

Canadian Institutes of Health Research (CIHR)

Collaborator

Trials
1,417
Recruited
26,550,000+

Published Research Related to This Trial

Among 2,741 cancer survivors, 13.8% reported practicing weight-loss restrictive diets, with a higher prevalence in women, those who are overweight/obese, and individuals with breast cancer, indicating a significant trend towards dietary control post-diagnosis.
Fasting was practiced by 6.0% of participants, often associated with the belief that it could improve cancer prognosis; however, those receiving nutritional guidance from healthcare professionals were less likely to engage in fasting or restrictive diets, highlighting the importance of professional dietary advice.
Fasting and weight-loss restrictive diet practices among 2,700 cancer survivors: results from the NutriNet-Santé cohort.Fassier, P., Srour, B., Raynard, B., et al.[2019]
A predominantly plant-based diet, along with regular physical activity and maintaining a healthy weight, plays a crucial role in preventing breast cancer and supporting treatment.
The article emphasizes the importance of personalized lifestyle recommendations for patients, based on evidence from the World Cancer Research Fund/American Institute for Cancer Research, to enhance cancer prevention strategies.
Breast Cancer: A Lifestyle Medicine Approach.Orman, A., Johnson, DL., Comander, A., et al.[2021]
In a study involving 172 women undergoing chemotherapy, intermittent energy restriction (IER) showed a trend towards greater weight and body fat reduction compared to continuous energy restriction (CER), particularly after adjusting for body water.
While the overall incidence of severe chemotherapy toxicities was similar between IER and CER, there was a trend indicating fewer severe toxicities in the IER group during later cycles of treatment, suggesting IER may help reduce treatment-related side effects.
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer.Harvie, M., Pegington, M., Howell, SJ., et al.[2022]

Citations

a randomised controlled trial of the effect of time-restricted ...The purpose of this study is to evaluate the effect of a multimodal intervention consisting of TRE, healthy eating, and reduced sedentary time during ...
Time Restricted Eating During Chemotherapy for Breast ...The proposed research will demonstrate that time restricted eating, a form of intermittent fasting, will improve treatment related outcomes, patient related ...
Clinical Impact of Time-restricted Eating on CancerPreliminary findings suggest that TRE is feasible and acceptable by people with cancer, may have oncological benefits, and improves quality of life.
Time-Restricted Eating: A Novel and Simple Dietary ...In composite, these data suggest that TRE may be an easy and novel lifestyle interventions for the primary and secondary prevention of breast cancer, as well as ...
The effects of lifestyle and behavioural interventions on ...This study aimed to assess and compare the effects of lifestyle/behavioural interventions on cancer recurrence, survival and QoL in breast cancer survivors.
Abstract 12484: Weekday 16:8 Time-Restricted Eating in ...Eight weeks of weekday 16:8 TRE is highly feasible, safe, and reduces CVD risk among older breast cancer survivors with overweight/obesity at moderate CVD risk.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security